EDGAR Filing Documents for 0001396814-14-000003

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001396814-14-000003

Filing Date

2014-02-25

Accepted

2014-02-25 15:13:37

Documents

Period of Report

2013-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	pcrx-12312013x10k.htm	10-K	2070412
2	EXHIBIT 10.46	exhibit1046.htm	EX-10.46	143699
3	EXHIBIT 10.47	exhibit1047.htm	EX-10.47	50169
4	EXHIBIT 10.48	exhibit1048.htm	EX-10.48	51030
5	EXHIBIT 21.1	exhibit211.htm	EX-21.1	1983
6	EXHIBIT 23.1	exhibit231.htm	EX-23.1	4227
7	EXHIBIT 31.1	pcrx-12312013xex311.htm	EX-31.1	11672
8	EXHIBIT 31.2	pcrx-12312013xex312.htm	EX-31.2	11370
9	EXHIBIT 32.1	pcrx-12312013xex321.htm	EX-32.1	4923
10	EXHIBIT 32.2	pcrx-12312013xex322.htm	EX-32.2	4870
17		performancegraph.jpg	GRAPHIC	70598
	Complete submission text file	0001396814-14-000003.txt		11493646

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE DOCUMENT	pcrx-20131231.xml	EX-101.INS	1639252
12	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	pcrx-20131231.xsd	EX-101.SCH	70836
13	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	pcrx-20131231_cal.xml	EX-101.CAL	97984
14	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	pcrx-20131231_def.xml	EX-101.DEF	268269
15	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	pcrx-20131231_lab.xml	EX-101.LAB	926196
16	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	pcrx-20131231_pre.xml	EX-101.PRE	479126

Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)